[In vitro sensitivity of meningococci and the implications for prevention].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004357:Drug Synergism; D004917:Erythromycin / Q000494:pharmacology; D007933:Leucomycins / Q000494:pharmacology; D008589:Meningococcal Infections / Q000517:prevention & control; D009345:Neisseria meningitidis / Q000187:drug effects*; D010068:Oxacillin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D012293:Rifampin / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D004917:Erythromycin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D010400:Penicillin G; D010068:Oxacillin; D012293:Rifampin
Etude de la sensibilité in vitro des méningocoques et son implication en prophylaxie.